Cannabis Use in the Childbearing Years: An Evidence Summary for Healthcare Providers
Attributes to meet: PDF: Download File, Reports
Download File: condition met
Report, 2018
Due to the legalization of cannabis in Canada, and for the health of children and families, there is a growing need to provide parents, prospective parents, healthcare professionals, and other service providers with evidence-based information about the potential risks of cannabis use. This evidence summary is for healthcare providers. It provides general information about cannabis and rates of cannabis use in Canada, as well as information about the potential risks of cannabis use before, during, and after pregnancy. This summary also offers several recommendations for public messaging based on the available research.
Related products
-
Group Prenatal Care Lit Review
Report, 2016
Group prenatal care is a model of group where eight to twelve women of similar gestational age meet as a group with their healthcare provider for 90-120 minutes of regularly scheduled appointments, starting in their second trimester and continuing throughout their pregnancy. During these appointments, each woman has a brief individual physical assessment with the healthcare provider and then participates in a group discussion led by a healthcare provider. All prenatal care is provided in this group setting, combining the usual physical assessment with peer support and increased time for education about healthy pregnancy. This report examines current research on group prenatal care to assess if it is a good model of care for Saskatchewan and if there is an improvement in birth outcomes and breastfeeding rates associated with using this model of care compared to individual prenatal care. Birth outcomes examined in this report are gestational age at birth, preterm birth, and low birth weight.
SKU: 2-903 -
HIV and Pregnancy – A Guide to Care
Guide and Manual, Revised 2020
This guide covers such topics such as HIV/AIDS in Saskatchewan, modes of transmission of HIV, HIV testing during pregnancy, prenatal algorithm, HIV treatment and drug management, after-care for babies of HIV positive women, barriers to HIV transmission prevention and prenatal care, and motivational approaches.
For updated information about HIV/AIDS for health professionals, visit: https://www.canada.ca/en/public-health/services/diseases/hiv-aids/health-professionals.html.
For updated HIV order sets for Saskatchewan, including maternal and infant order sets, clinical forms, and discharge checklists, visit: https://www.saskhealthauthority.ca/intranet/health-provider-resources/clinical-resources/z-list-clinical-resources/maternalchildrens-health-resources/hiv-maternal-and-newborn-clinical-resources.
For updated information about infant feeding recommendations in Canada, including criteria for people living with HIV who want to breastfeed, visit: https://pubmed.ncbi.nlm.nih.gov/37008587/.
SKU: 7-008 -
HIV and Pregnancy
Poster, 2022
HIV can be passed from a pregnant person to their growing baby during pregnancy. This poster brings awareness to the importance of HIV testing, treatment, and prenatal care for the health of pregnant people and their babies.
SKU: 7-004 -
Folic Acid and the Prevention of Neural Tube Defects
Fact Sheet, 2016
Provides information on neural tube defects and the importance of taking folic acid before becoming pregnant.
SKU: 2-301